financetom
KMB
financetom
/
Consumer Staples
/
KMB
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Kimberly-Clark CorporationKMB
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide.

It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.

Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names.

The company's K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands.

In addition, it sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce.

The company was founded in 1872 and is headquartered in Dallas, Texas.

Latest News >
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
May 26, 2025
10:03 AM EDT, 05/13/2025 (MT Newswires) -- Bright Minds Biosciences ( DRUG ) said Tuesday that its BMB-101 showed a complete elimination of drop attacks in the DBA/2 mouse model of epilepsy. Notably, BMB-101 achieved 100% survival in the DBA/2 model, reversing brainstem serotonin deficits and preventing seizure-induced respiratory arrest, Jan Torleif Pedersen, the company's chief science officer, said. The...
GM, LG to make new, lower-cost cells for future EVs
GM, LG to make new, lower-cost cells for future EVs
May 26, 2025
DETROIT (Reuters) -General Motors ( GM ) and battery partner LG Energy Solution are planning to start commercial production of lower-cost cells for future electric vehicles at a U.S. facility starting in 2028, the companies said on Tuesday.  The cells will have a lithium manganese-rich (LMR) chemistry, which GM says is lower cost than the nickel-rich cells used today, but...
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
May 26, 2025
10:05 AM EDT, 05/13/2025 (MT Newswires) -- OMS Energy Technologies ( OMSE ) said Tuesday it priced its initial public offering of about 3.7 million ordinary shares at $9 per share. The total base offering size is $33.3 million, assuming the underwriters don't exercise their 45-day option to buy up to 555,555 additional ordinary shares at the IPO price, the...
Bank of America to open more than 150 new branches by 2027
Bank of America to open more than 150 new branches by 2027
May 26, 2025
May 13 (Reuters) - Bank of America ( BAC ) plans to open more than 150 new branches by the end of 2027, it said on Tuesday, as part of the lender's efforts to expand its physical presence across the United States. The bank will open 40 new branches this year, with an additional 70 sites planned for 2026, it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved